To determine whether MEK inhibition could influence HCC cell growth, HCC cells were treated with the MEK inhibitor U0126 (5 μm–20 μM) or AZD6244 (5 μm–20 μM) for 48 hours. The gene discussed is MAP2K7; the disease is hepatocellular carcinoma.